Background
==========

Stroke is the leading cause of long-term disability in the United States[@b1-ijwh-6-585] and ranks fourth among all causes of death, behind diseases of the heart, cancer, and chronic lower respiratory diseases.[@b2-ijwh-6-585]--[@b4-ijwh-6-585] Stroke incidences also differ by sex, exhibiting the classical "female paradox" phenomenon; while the incidence of stroke is greater among men, women suffer worse outcomes from the disease.[@b3-ijwh-6-585],[@b5-ijwh-6-585] Several studies have highlighted this differential effect of sex on stroke. Di Carlo et al[@b6-ijwh-6-585] reported that women are 41% more likely to have worse disability following stroke than men. Moreover, some 60% of stroke deaths in 2008 occurred among women.[@b1-ijwh-6-585] Additional studies have also identified differences not only in the risk profiles between the sexes, but also between racial/ethnic groups.[@b7-ijwh-6-585]--[@b9-ijwh-6-585]

In considering sex differences in the incidence and mortality from stroke, some studies have reported a correlation between menopause, with its concomitant changes in arterial structure, and the worsening of biochemical risk factors for atherosclerosis.[@b10-ijwh-6-585]--[@b21-ijwh-6-585] Others point to an increased prevalence of metabolic syndromes among menopausal women as responsible for the disparity in stroke between the sexes.[@b12-ijwh-6-585] Increasing evidence implicates dyslipidemia and elevated triglycerides and total cholesterol (TC) levels as important but modifiable risk factors for stroke.[@b2-ijwh-6-585],[@b13-ijwh-6-585]

The association between higher levels of triglycerides and stroke, however, is tenuous at best.[@b14-ijwh-6-585],[@b15-ijwh-6-585] Interpreting the relationship between TC and stroke is often confounded by the type of stroke under consideration (ischemic versus hemorrhagic). The MR FIT (Multiple Risk Factor Intervention Trial) showed that the risk for hemorrhagic stroke was inversely related to TC levels; however, risk for ischemic stroke increased as TC levels exceeded 200 mg/dL. In fact, the risk for ischemic stroke more than doubled when TC levels exceeded 280 mg/dL.[@b16-ijwh-6-585] Similar results were shown in a health maintenance organization-based case-control study by Tirschwell et al,[@b17-ijwh-6-585] which reported an increased risk of certain subtypes of ischemic stroke with higher TC and lower high-density lipoprotein (HDL) levels. However, only a few prospective studies with racially/ethnically diverse populations have examined the associations between the subtypes of ischemic stroke and lipid abnormalities such as hypercholesterolemia (high levels of TC and triglycerides).[@b18-ijwh-6-585],[@b19-ijwh-6-585]

Because of the increasing diversity and aging of the US population, identification of specific risk factors for each racial/ethnic group by sex may help further improve outcomes following stroke. Such information may even help devise practical preventive and interventional approaches to stroke care in these subpopulations. In this study, we examined the impact and prognostic influence of stroke risk factors at the time of stroke admission. We evaluated lipid profiles, specifically the severity of hypercholesterolemia and triglyceride levels, in predicting the risk for the subtypes of ischemic stroke between the sexes and within the different racial/ethnic groups in a large cohort of hospitalized stroke patients.

Methods
=======

Data on acute stroke admissions was prospectively collected at a comprehensive stroke center serving a racially/ethnically diverse population in Northern New Jersey. All data elements related to stroke diagnosis, treatment, and outcomes were abstracted from the medical records by trained personnel using a fixed algorithm and entered into a computerized registry system. These data included all elements of Center for Disease Control's Coverdell registry, including the National Institutes of Health Stroke Scale scoring system for severity of outcome and the Trial of ORG 10 172 in Acute Stroke Treatment (TOAST) for etiologic classifications of ischemic stroke.[@b20-ijwh-6-585]

Study populations
-----------------

A total of 3,290 acute stroke admissions between 2006 and 2010 who met the racial/ethnic criteria (White, African American, South Asian, or Hispanic) and were ≥18 years of age were selected for this analysis. A surname method of racial/ethnic classification, a validated method that has been used in several previous studies, including the US Census Bureau among others,[@b21-ijwh-6-585]--[@b24-ijwh-6-585] was used to identify subjects in the South Asian race/ethnicity category.

Stroke subtypes
---------------

All subjects had computed tomography (CT) scans of the brain at the time of initial evaluation and again in 24 hours. The majority of patients also underwent magnetic resonance (MR) imaging of the brain. Some patients had extra-cranial vascular imaging using CT angiography and MR angiography. The remainder of the patients underwent carotid duplex ultrasound. Patients undergoing CT angiography or MR angiography also had intracranial vascular imaging, as well as two-dimensional trans-thoracic echocardiography. In addition, those with a strong suspicion for an embolic source underwent trans-esophageal imaging. Patients also underwent either Holter monitoring or a minimum of 24 hours of telemetric cardiac monitoring. A stroke-trained neurologist performed the TOAST criteria for the etiologic classifications of ischemic stroke. Of 3,290 acute stroke admissions, 47% (1,541) were diagnosed as ischemic stroke and were selected for the TOAST classification as either large-artery atherosclerosis (LAA), cardioembolism (CE), small-artery occlusion (SAO), other determined/known cause, and undetermined/unknown causes (including two or more of the above).[@b20-ijwh-6-585],[@b25-ijwh-6-585] For this analysis, we combined the last two categories.

Stroke risk factors
-------------------

The following vascular risk factors were evaluated: age, sex, and history of hypertension, diabetes mellitus, dyslipidemia, and smoking (any smoking within a year prior to admission). Test results of systolic/diastolic blood pressures, fasting blood glucose, glycated hemoglobin (HbA~1c~), lipids (TC, HDL/low-density lipoprotein \[LDL\], and triglycerides) and coagulation profiles were completed both upon admission and within 48 hours following admission for acute stroke. Additional variables collected included any current treatment with antihypertensives, diabetic medications, or cholesterol-reducing medications. Following the criteria for classification in diagnosis of diabetes by the American Diabetes Association,[@b26-ijwh-6-585] we conducted a separate analysis to examine plasma TC levels using the following categories (where TC \<200 mg/dL = desirable, TC =200--239 mg/dL = borderline high, and TC \>240 mg/dL = high). Furthermore, we examined the conflicting evidence[@b27-ijwh-6-585] that an overall high level of LDL is a potent risk factor for the incidence of stroke, by examining the extent to which acute stroke patients in our cohort had LDL cholesterol (LDL-c) levels ≥100 mg/dL within the first 48 hours after their hospital arrival or 30 days prior to their stroke admissions.

Statistical analysis
--------------------

A two-part analysis was carried out. The first part focused on the entire cohort of stroke admissions and assessed socio-demographic variables, the prevalence of stroke risk factors, and clinical profiles by sex within racial/ethnic group. Summary data are expressed as means ± standard deviations for interval data and as proportions for categorical variables. Because triglycerides, HbA~1c~, and fasting blood glucose values were positively skewed, natural logarithmic transformation was used, and results were expressed as geometric means with 95% confidence intervals (CIs). Testing for differences between sexes within racial/ethnic groups was done using the chi-square test (or Fisher's exact test for small cell counts) for categorical variables and analysis of variance for interval measures.

In the second part of the analysis, a regression model was fitted with ischemic stroke etiologic subtypes LAA and SAO as dependent variables and patient lipid profiles (TC, HDL, and triglycerides), age, history of smoking, and history of dyslipidemia as independent variables to predict the risk of developing LAA versus SAO by sex within a racial/ethnic group. The regression model fitted was a "modified Poisson" approach with "sandwich error estimation" using the SAS PROC GENMOD procedure with REPEATED statement (patient ID, in our data) fitted to estimate (the relative risk \[RR\] and 95% CIs) for the probability of developing large vessel disease (LAA versus SAO) after adjusting for several confounding factors. All analyses were carried out using SAS statistical software, version 9.2 (SAS Institute Inc., Cary, NC, USA). Results were considered significant if *P*\<0.05. Institutional Review Board approval to evaluate the stroke registry data for this project was obtained both from the JFK Medical Center and the University of Medicine and Dentistry of New Jersey.

Results
=======

Patient characteristics and clinical measurements at the time of admission are detailed in [Table 1](#t1-ijwh-6-585){ref-type="table"}. Stroke admissions were less common among South Asian and Hispanic women (40.7% and 46.9%, respectively) as compared with their male counterparts; however, the inverse was true for Whites and African Americans. White women were significantly older than their male counterparts (75.3 versus 70.3, respectively; *P*\<0.0001), but no significant age differences were observed between the sexes of the remaining racial/ethnic groups.

For all racial/ethnic groups except South Asians, females had higher mean plasma TC levels than their male counterparts. The largest difference by sex was observed among African Americans, where the average TC levels among women were 18.1 mg/dL points higher than that of men (*P*\<0.0001) ([Table 1](#t1-ijwh-6-585){ref-type="table"}). The difference in TC can be partially explained by the fact that women had statistically significantly higher HDL levels than men (*P*=0.001). LDL levels within most racial/ethnic groups were also higher among women; only South Asian women had lower LDL plasma concentration levels than their male counterparts ([Table 1](#t1-ijwh-6-585){ref-type="table"}). Overall, females had a slightly higher mean body mass index (BMI in kg/m^2^) than males, except among Whites, where male stroke patients were significantly heavier than females (*P*=0.0059). None of the by-sex comparisons of triglycerides, blood pressure, HbA~1c~, and fasting blood glucose levels were found to be statistically significantly different. We also found that examination of plasma TC levels by the categories showed that patients with TC plasma levels \>240 mg/dL, where the risk for coronary artery disease is considered to be greatest, were consistently higher among females than males. We have also noticed inconsistent trends for other clinical characteristics of study subjects; we have provided the details of our findings in this regard in [Table S1](#SD1-ijwh-6-585){ref-type="supplementary-material"} for reference.

Examination of the extent to which acute stroke patients in our cohort had LDL-c levels ≥100 mg/dL within the first 48 hours after their hospital arrival or 30 days prior to their stroke admissions showed that women of all racial/ethnic groups, except for the South Asians, had higher likelihood of having LDL-c levels that are ≥100 mg/dL on admission than their male counterparts ([Table 2](#t2-ijwh-6-585){ref-type="table"}). The proportion of patients who had prescriptions for cholesterol reducing medications (statins) at the time of their admission and at discharge were higher among White and African American females, while South Asian and Hispanic males had higher frequencies of these prescriptions ([Table 2](#t2-ijwh-6-585){ref-type="table"}).

Similarly, White and African American females were more likely to be on medications for hypertension or diabetes, and on anticoagulation at the time of admission than their male counterparts, while the reverse relationship was found within Hispanic and South Asian patients ([Table 3](#t3-ijwh-6-585){ref-type="table"}). Stroke risk factors such as hypertension, diabetes mellitus, cardiac diseases, dyslipidemia, and previous history of stroke/transient ischemic attack (TIA) were more prevalent among South Asian and Hispanic men than women ([Table 3](#t3-ijwh-6-585){ref-type="table"}). Histories of cigarette smoking were statistically significantly higher among males than females of all racial/ethnic groups. The largest difference in the proportion of smoking were seen among South Asians, where the proportion of smoking was substantially higher among men than women (*P*=0.0005).

The final diagnosis (type of stroke) for acute stroke admissions between the sexes within the racial/ethnic groups are detailed in [Table 4](#t4-ijwh-6-585){ref-type="table"}. Among patients with the incidence of ischemic stroke, South Asians (58.8%) and Hispanics (52.4%) had higher proportions of men than women with ischemic stroke diagnosis, while the inverse was true among White and African Americans. Although similar trends were observed among those diagnosed with TIA and subarachnoid hemorrhage, the incidences of intracerebral hemorrhage were consistently higher among males of all racial/ethnic groups albeit not statistically significantly so ([Table 4](#t4-ijwh-6-585){ref-type="table"}). A closer examination of patients with only ischemic stroke diagnoses (n=1,541) reveals that the LAA subtype was more common among women of all racial/ethnic groups except Hispanics, where Hispanic men had a higher proportion of patients with this etiologic subtype ([Table 4](#t4-ijwh-6-585){ref-type="table"}). Similarly, and consistent with previous studies,[@b28-ijwh-6-585] the incidence of SAO was more common among women than men, except among South Asians, where men tended to have a higher rate of diagnosis of this subtype when compared by sex. The biggest difference in the sex comparison for CE was observed among South Asians, where men were almost four times as likely to have CE diagnosis as compared with women ([Table 4](#t4-ijwh-6-585){ref-type="table"}).

In the second part of the analysis, we examined the extent to which stroke risk factors (history of hypertension, diabetes mellitus, smoking, and dyslipidemia, as well as blood levels of LDL, HDL, and triglycerides as measures of hypercholesterolemia) are associated with the risk of the specific ischemic stroke subtypes (LAA and SAO) between the sexes and within racial/ethnic groups. The details for the logistic regression analysis by sex within a racial/ethnic group are detailed in [Table 5](#t5-ijwh-6-585){ref-type="table"}. This analysis revealed that age was a statistically significant predictor for the increased risk of developing LAA among South Asian and White women. For every 10-year increase in age, South Asian woman had a 27% (RR =1.27, 95% CI 1.02--1.58) increased risk of developing LAA versus SAO. Likewise, White women had a 20% (RR =1.20, 95% CI 1.06--1.37) increased risk. This may be because women are more likely to suffer from SAO at younger ages; and thus, those without the incidence of SAO are effectively at increased risk for developing LAA as they advance in age. The same increase in age also raised the risk for LAA among African American men by 22% (RR =1.22, 95% CI 1.05--1.41). Similarly, raised risks for LAA were also observed among Hispanic men and women, albeit not statistically significantly ([Table 5](#t5-ijwh-6-585){ref-type="table"}). White women who reported a history of smoking were 82% more likely to develop LAA as opposed to SAO (RR =1.82, 95% CI 1.36--2.45); although the risk for the development of LAA (versus SAO) was raised among White and African American men with history of smoking, this association did not meet statistical significance at the *P*=0.05 level. Moreover, due to the very small number of women who have reported any history of smoking among South Asian and Hispanics, smoking was dropped from the regression analysis for these two racial/ethnic groups.

The assessment of hypercholesterolemia at the time of admission for acute stroke showed that only HDL and triglycerides resulted in marginally significant correlation with the risk of developing LAA (as opposed to SAO) in this cohort. A 10 mg/dL increase in the blood plasma levels of HDL reduced the risk for developing LAA among African American men by 25% (RR =0.75, 95% CI 0.61--0.93) and White women by 12% (RR =0.88, 95% CI 0.80--0.96) ([Table 5](#t5-ijwh-6-585){ref-type="table"}). On the other hand, plasma triglyceride levels did not show statistically significant differential effect by sex within racial/ethnic groups. Finally, in this analysis, none of the effects for interaction terms were statistically significant, and so these terms were dropped from the final models.

Conclusion
==========

Stroke has a greater effect on women than men due to the fact that women tend to have more stroke events and are less likely to recover from them. Studies have shown that one in six women die of stroke as compared with the one in 25 who die from cancer.[@b29-ijwh-6-585] Although age-specific stroke rates are higher in men, because of women's longer life expectancy, they suffer a much higher incidence of stroke at older ages and thus bear a heavier burden of the disease.[@b5-ijwh-6-585] There is also disparity in the mortality rates from stroke by race/ethnicity. For example, mortality for African Americans is about 33% greater than that for Whites.[@b2-ijwh-6-585] However, few studies have compared risk factors and stroke subtypes between males and females within racial/ethnic groups.

In this study, sex comparison within racial/ethnic groups reveals that females had a greater prevalence of dyslipidemia compared with males. Except among the South Asian population, where woman had significantly higher levels of circulating blood LDL (≥100 mg/dL) concentrations at the time of stroke presentation. The benefits of having higher HDL in circulating blood are only evident among South Asian women, where LDL and TC levels were reduced owing to a characteristic advantage of having higher levels of plasma HDL.[@b26-ijwh-6-585] This may be indicating an uncontrolled pre-stroke hypercholesterolemia among women of all racial/ethnic groups except the South Asians, a fact that was apparent by the greater incidence of ischemic and hemorrhagic stroke among hypercholesterolemic women than men.

The result of the examination of the well understood and studied stroke risk factors (hypertension, diabetes mellitus, dyslipidemia, smoking, cardiac diseases, and history of previous stroke or TIA) among our study subjects is consistent with the stroke literature.[@b21-ijwh-6-585],[@b30-ijwh-6-585] History of smoking was higher among males of all racial/ethnic groups. However, all other risk factors analyzed in this study followed a consistent pattern: a higher prevalence in White and African American females compared with their male counterparts, with the reverse trend in the South Asian and Hispanic populations. Analysis by stroke subtype shows the same group, White and African American females with South Asian and Hispanic males had a higher prevalence of ischemic stroke compared with the opposite sex within race/ethnicity. This may point to a yet unexamined or not fully understood correlation between nativity, culture, and stroke risk factors in the United States.

The regression analysis showed several significant associations between cardiovascular risk factors and ischemic stroke subtypes. However, our data showed no factors that could be consistently used to predict LAA versus SAO in acute stroke patients. The risk for LAA increased with age in White and South Asian females and in African American males. HDL proved to be a protective factor for LAA in White females but not for women in other racial/ethnic groups. A positive smoking history dramatically increased risk for LAA in White women compared with White and African American men. While our results did not demonstrate significant association between triglycerides or LDL levels and type of stroke, future studies with larger sample sizes may be able to elucidate the relationship between dyslipidemia and stroke subtypes.

Despite the similarity in their average ages with their sex counterparts, South Asian women and African American men were more likely to suffer from a specific etiologic type of ischemic stroke (LAA) at a younger age than previously reported.[@b22-ijwh-6-585] However, the overall result of our study was consistent with those of other studies like the Framingham Study, the Copenhagen Study, and the Israeli Heart Disease Study, which have all demonstrated a trend toward reduced risk of stroke with increasing HDL cholesterol levels in men.[@b23-ijwh-6-585] In our study, however, the increase in plasma HDL levels was more beneficial to African American women than men, while similar increases in HDL levels seem to have equal impacts on the risk of developing LAA among both sexes of South Asians. Population-based studies have shown that, overall, Blacks and men have higher TIA rates when compared with Whites and women.[@b24-ijwh-6-585] We also found that African American women had a higher proportion of patients with the incidence of TIA.

This study was limited in its ability to account for all stroke risk factors including diet, activity levels, and alcohol consumption, which may have contributed to racial/ethnic variations in the incidence of stroke. The dataset used for this study has the advantages of timeliness and quality, as well as racial/ethnic diversity. It may, however, suffer from inherent limitation of hospital-based registries in over-representing a specific racial/ethnic or socioeconomic group. That is, most of the common stroke risk factors such as hypertension, smoking, dyslipidemia, cardiac diseases, TC levels, and diabetes mellitus were also major risk factors for stroke among our racially/ethnically diverse cohort.

Our by-sex comparison showed that the prevalence of most stroke risk factors examined in this study was greater among White and African American women, South Asian and Hispanic men than their sex counterparts. We suppose that this may be a result of a confluence of factors such as lower rates of health insurance, lower utilization of health care services, or lower quality of care. The consistent pattern we observed may also be related to cultural norms and nativity, or it may reflect inherent biological differences and predisposition to disease. Future studies of racially diverse populations in different locations are needed in order to confirm these trends and begin to appropriate the relative influence of cultural and genetic factors.

Although the associations observed here do not prove causation, future prospective epidemiologic studies with diverse populations with known and suspected stroke risk factors should be conducted to adequately address important public health policy issues. These include access to both preventive and service coverage for the growing immigrant populations.

Supplementary material
======================

###### 

Category of clinical characteristic measures on admission, by sex within racial/ethnic groups, in percentages

                                                                                Sex                                              
  ----------------------------------------------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------
  TC, %                                                                                                                          
   Desirable (TC \<200 mg/dL)                                                   67.4   66.4   68.5   57.4   61.4   57.3   68.5   57.5
   Borderline high (TC 200--239 mg/dL)                                          10.8   14.3   13.0   11.8   14.5   19.1   10.8   19.2
   High (TC \>240 mg/dL)                                                        5.1    5.0    6.8    7.3    6.8    9.4    7.2    9.2
   Missing                                                                      16.7   14.3   11.7   23.5   17.4   14.1   13.5   14.2
  LDL, %                                                                                                                         
   Near/above optimal (LDL \<129 mg/dL)                                         66.5   66.4   64.2   56.6   64.5   60.1   70.3   61.6
   Borderline high (LDL 130--159 mg/dL)                                         11.1   13.5   16.7   13.2   11.0   13.3   9.9    14.2
   High (LDL 160--189 mg/dL)                                                    4.6    5.7    6.2    5.9    5.2    10.2   2.7    7.5
   Very high (LDL ≥190 mg/dL)                                                   2.0    1.6    1.8    2.2    2.4    2.5    4.5    2.5
   Missing                                                                      15.8   12.7   11.1   22.1   16.9   13.9   12.6   14.2
  HDL, %                                                                                                                         
   Low (HDL \<40 mg/dL)                                                         46.1   43.9   54.3   44.9   27.9   24.1   30.6   34.2
   Mid-range (40 mg/dl ≤ HDL \<60 mg/dL)                                        32.5   34.8   30.9   27.2   40.5   46.3   46.0   45.8
   High (HDL ≥60 mg/dL)                                                         4.5    7.4    3.1    4.4    14.1   15.5   9.9    5.8
   Missing                                                                      16.8   13.9   11.7   23.5   17.5   14.1   13.5   14.2
  TG, %                                                                                                                          
   Normal (TG \<150 mg/dL)                                                      62.9   71.7   61.7   58.1   63.7   73.4   55.9   63.3
   Borderline high (TG 150--199 mg/dL)                                          12.5   9.8    14.2   8.8    12.2   8.3    19.8   9.2
   High (TG 200--499 mg/dL)                                                     7.4    4.5    12.4   8.8    6.3    4.4    9.9    12.5
   Very high (TG ≥500 mg/dL)                                                    0.4    0.4    0.6    0.7    0.3    0.0    0.9    0.8
   Missing                                                                      16.8   13.5   11.1   23.5   17.5   13.9   13.5   14.2
  Blood Pressure Classification, %[a](#tfn27-ijwh-6-585){ref-type="table-fn"}                                                    
   Normal (≤120/80 mmHg)                                                        42.5   31.2   34.6   38.2   43.8   37.1   36.0   42.5
   Prehypertension (120--139/80--89 mmHg)                                       20.7   22.5   26.5   27.9   20.8   21.6   18.0   20.8
   Stage 1 hypertension (140--159/90--99 mmHg)                                  19.0   20.5   14.8   14.0   15.0   16.3   18.0   11.7
   Stage 2 hypertension (\>160/100 mmHg)                                        11.4   18.9   19.8   10.3   13.0   14.4   18.0   16.7
   Missing                                                                      6.4    7.0    4.3    9.6    7.4    10.5   9.9    8.3
  Blood glucose classification, %[b](#tfn28-ijwh-6-585){ref-type="table-fn"}                                                     
   FBG \<126 mm/dL[c](#tfn29-ijwh-6-585){ref-type="table-fn"}                   54.1   49.2   58.0   46.3   57.0   50.4   41.4   51.7
   FBG ≥126 mm/dL                                                               35.0   40.2   35.8   41.2   31.1   35.7   46.0   38.3
   Missing                                                                      10.9   10.6   6.2    12.5   11.7   13.9   12.6   10.0
  HbA~1c~ classifications, %[b](#tfn28-ijwh-6-585){ref-type="table-fn"}                                                          
   HbA~1c~ \<6.5%                                                               44.0   39.3   38.3   39.0   44.8   37.1   29.7   42.5
   HbA~1c~ ≥6.5%                                                                19.3   27.1   32.7   27.2   16.5   30.2   43.2   21.7
   Missing                                                                      36.8   33.6   29.0   33.8   38.7   32.7   27.0   35.8
  BMI, %[c](#tfn29-ijwh-6-585){ref-type="table-fn"}                                                                              
   Underweight (BMI ≤18.5 kg/m^2^)                                              0.5    1.6    1.9    0.0    3.6    2.5    4.5    2.5
   Normal (BMI \<24.9 kg/m^2^)                                                  29.2   29.2   49.4   25.0   35.1   20.2   36.0   23.3
   Overweight (25.0\< BMI \<29.9 kg/m^2^)                                       36.1   32.8   29.6   41.9   27.1   28.8   24.3   33.3
   Obese (BMI ≥30.0 kg/m^2^)                                                    24.1   25.8   14.8   22.8   22.1   33.8   19.8   30.8
   Missing                                                                      10.1   9.8    4.3    10.3   12.1   14.7   15.3   10.0

**Notes:**

Blood pressure level based on the seventh report of the Joint National Committee on Hypertension, (JNC7)

classification based on the criteria for diagnosis of diabetes by the American Diabetes Association, 2010

BMI based on the Centers for Disease Control and Prevention BMI guidelines for weight status.

**Abbreviations:** BMI, body mass index; FBG, fasting blood glucose; HbA~1c~, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TC, total cholesterol; TG, triglycerides.
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###### 

Characteristics of patients with acute stroke on admission, by sex within racial/ethnic groups

  Characteristic                                                                                     Race/ethnicity                                                       
  -------------------------------------------------------------------------------------------------- ---------------------- ---------------------- ---------------------- ----------------------
  Female, %[a](#tfn1-ijwh-6-585){ref-type="table-fn"}                                                55.0                   59.7                   40.7                   46.9
  Mean age in years (± SD)                                                                                                                                                
   Male                                                                                              70.3 (14.2)            64.3 (13.2)            64.5 (13.8)            62.8 (14.7)
   Female                                                                                            75.3 (14.2)            64.9 (15.4)            66.0 (15.6)            65.1 (17.4)
   *P*-value[a](#tfn1-ijwh-6-585){ref-type="table-fn"}                                               \<0.0001               NS                     NS                     NS
  **Clinical measurements on admission**                                                                                                                                  
  Mean TC in mg/dL (± SD)[b](#tfn2-ijwh-6-585){ref-type="table-fn"}                                                                                                       
   Male                                                                                              165.2 (42.9)           166.6 (48.3)           172.8 (44.2)           171.2 (54.3)
   Female                                                                                            176.9 (45.2)           184.7 (45.2)           171.5 (46.1)           183.1 (45.0)
   *P*-value[b](#tfn2-ijwh-6-585){ref-type="table-fn"},[c](#tfn3-ijwh-6-585){ref-type="table-fn"}    \<0.0001               \<0.0001               NS                     NS
  Mean HDL in mg/dL (± SD)[b](#tfn2-ijwh-6-585){ref-type="table-fn"}                                                                                                      
   Male                                                                                              39.6 (11.3)            40.7 (14.4)            39.4 (11.6)            38.3 (11.5)
   Female                                                                                            46.6 (14.6)            48.1 (15.0)            44.5 (11.8)            43.7 (10.4)
   *P*-value[b](#tfn2-ijwh-6-585){ref-type="table-fn"},[c](#tfn3-ijwh-6-585){ref-type="table-fn"}    \<0.0001               \<0.0001               0.0010                 0.0006
  Mean LDL in mg/dL (± SD)[b](#tfn2-ijwh-6-585){ref-type="table-fn"}                                                                                                      
   Male                                                                                              101.8 (37.1)           103.1 (38.3)           108.4 (37.4)           110.4 (44.3)
   Female                                                                                            106.1 (39.6)           115.9 (38.5)           101.5 (39.1)           112.1 (36.1)
   *P*-value[b](#tfn2-ijwh-6-585){ref-type="table-fn"},[c](#tfn3-ijwh-6-585){ref-type="table-fn"}    0.0177                 0.0006                 NS                     NS
  Mean systolic blood pressure in mmHg (± SD)                                                                                                                             
   Male                                                                                              150.1 (28.3)           153.5 (32.2)           153.8 (31.9)           149.6 (27.6)
   Female                                                                                            154.8 (32.1)           154.0 (32.1)           161.6 (33.3)           154.1 (28.8)
   *P*-value[c](#tfn3-ijwh-6-585){ref-type="table-fn"}                                               0.0006                 NS                     NS                     NS
  Mean diastolic blood pressure in mmHg (± SD)[b](#tfn2-ijwh-6-585){ref-type="table-fn"}                                                                                  
   Male                                                                                              83.1 (17.8)            87.3 (21.2)            87.1 (18.1)            83.3 (16.3)
   Female                                                                                            82.4 (19.4)            85.4 (19.3)            88.0 (25.2)            82.5 (18.3)
  Mean body mass index in kg/m^2^ (± SD)[b](#tfn2-ijwh-6-585){ref-type="table-fn"}                                                                                        
   Male                                                                                              27.7 (5.5)             28.0 (6.4)             25.4 (4.3)             27.9 (4.3)
   Female                                                                                            27.1 (6.3)             29.8 (7.5)             26.5 (5.8)             28.8 (7.0)
   *P*-value[c](#tfn3-ijwh-6-585){ref-type="table-fn"}                                               0.0059                 0.0029                 NS                     NS
  Geometric mean fasting blood glucose in mg/dL (95% CI)[b](#tfn2-ijwh-6-585){ref-type="table-fn"}                                                                        
   Male                                                                                              125.0 (122.3--127.8)   126.9 (120.7--133.5)   126.5 (119.3--134.1)   128.5 (120.4--137.2)
   Female                                                                                            119.7 (117.4--121.9)   126.5 (121.3--131.8)   138.2 (127.6--149.8)   128.5 (119.3--138.4)
  Geometric mean HbA~1c~ in % (95% CI)[b](#tfn2-ijwh-6-585){ref-type="table-fn"}                                                                                          
   Male                                                                                              6.3 (6.2--6.4)         6.5 (6.3--6.7)         6.8 (6.5--7.0)         6.4 (6.2--6.7)
   Female                                                                                            6.2 (6.1--6.3)         6.5 (6.4--6.7)         6.9 (6.6--7.2)         6.4 (6.1--6.6)
  Geometric mean triglycerides in mg/dL (95% CI)[b](#tfn2-ijwh-6-585){ref-type="table-fn"}                                                                                
   Male                                                                                              107.6 (103.9--111.3)   92.9 (86.1--100.3)     115.9 (106.3--126.4)   107.9 (94.5--123.1)
   Female                                                                                            107.4 (104.2--110.6)   91.6 (86.5--97.0)      115.6 (104.0--128.4)   117.2 (106.3--129.2)

**Notes:**

χ^2^ test *P*\<0.0001.

Statistical test did not include missing values (\~12%--17% for TC, LDL/HDL and 35% for HbA~1c~); also *P*-values for variables that were not statistically significantly different by sex are not shown.

Analysis of variance for comparing means.

**Abbreviations:** CI, confidence interval; HbA~1c~, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NS, not significant at *P*=0.05 level; SD, standard deviation; TC, total cholesterol.

###### 

Percentage severity of hypercholesterolemia and lipid profiles for acute stroke patients, by sex within racial/ethnic groups

                                                                                         Race/ethnicity (N=3,290)   *P*-value[a](#tfn5-ijwh-6-585){ref-type="table-fn"}                   
  -------------------------------------------------------------------------------------- -------------------------- ----------------------------------------------------- -------- ------ --------
  **LDL-c level on admission ≥100 mg/dL, %[b](#tfn6-ijwh-6-585){ref-type="table-fn"}**                                                                                                    
  Yes (n=1,346)                                                                          47.9                       57.9                                                  52.8     56.2   0.0003
   Male                                                                                  42.6                       36.2                                                  63.6     48.7   
   Female                                                                                57.4                       63.8                                                  36.4     51.3   
  No (n=1,299)                                                                           52.1                       42.1                                                  47.2     43.8   
   *P*-value[c](#tfn7-ijwh-6-585){ref-type="table-fn"}                                   0.0462                     0.0111                                                NS       NS     
  **Cholesterol reducers on admission, %[d](#tfn8-ijwh-6-585){ref-type="table-fn"}**                                                                                                      
  Yes (n=1,394)                                                                          45.0                       37.3                                                  37.5     38.3   0.0007
   Male                                                                                  48.3                       43.1                                                  61.8     53.1   
   Female                                                                                51.7                       56.9                                                  38.2     46.9   
  No (n=1,890)                                                                           55.0                       62.8                                                  62.5     61.7   
   *P*-value[c](#tfn7-ijwh-6-585){ref-type="table-fn"}                                   0.0058                     NS                                                    NS       NS     
  **Cholesterol reducers at discharge, %**                                                                                                                                                
  Statin (n=1,852)[e](#tfn9-ijwh-6-585){ref-type="table-fn"}                             55.0                       60.5                                                  65.6     59.2   0.0027
   Male                                                                                  47.4                       40.2                                                  64.5     56.7   
   Female                                                                                52.6                       59.8                                                  35.5     43.3   
   *P*-value                                                                             0.0076                     NS                                                    0.0325   NS     
  Other medications                                                                      1.2                        0.8                                                   0.4      1.2    
  Contraindicated                                                                        5.4                        3.8                                                   4.0      7.0    
  None prescribed                                                                        37.3                       34.1                                                  31.3     28.6   

**Notes:**

χ^2^ test for differences between racial/ethnic groups

19.6% data missing

χ^2^ test differences between the sexes within a racial/ethnic group

less than 0.2% (n=6) data missing

about 6% data missing.

**Abbreviations:** LDL-c, low-density lipoprotein cholesterol; NS, not significant at *P*\<0.05 level.

###### 

Proportion of prescription medication use and the prevalence of most common stroke risk factors prior to admission, by sex within racial/ethnic groups

                                                                           Race/ethnicity                     
  ------------------------------------------------------------------------ ---------------- -------- -------- --------
  **History of prescription medication use**                                                                  
  Antihypertensive medications, %                                                                             
   Male                                                                    42.7             40.7     58.8     54.1
   Female                                                                  57.3             59.3     41.2     45.9
   *P*-value[a](#tfn11-ijwh-6-585){ref-type="table-fn"}                    0.0003           NS       NS       NS
  Cholesterol-reducing medications, %                                                                         
   Male                                                                    48.3             43.1     61.8     53.1
   Female                                                                  51.7             56.9     38.2     46.9
   *P*-value[a](#tfn11-ijwh-6-585){ref-type="table-fn"}                    0.0060           NS       NS       NS
  Antiplatelet medications, %[b](#tfn12-ijwh-6-585){ref-type="table-fn"}                                      
   Male                                                                    45.1             38.8     63.4     57.6
   Female                                                                  54.9             61.2     36.6     42.4
  Anticoagulant medications, %                                                                                
   Male                                                                    44.9             41.0     63.5     41.7
   Female                                                                  55.1             59.0     36.5     58.3
   *P*-value[a](#tfn11-ijwh-6-585){ref-type="table-fn"}                    NS               NS       NS       0.0216
  Diabetic medications, %                                                                                     
   Male                                                                    47.2             39.9     61.1     54.3
   Female                                                                  52.8             60.1     38.9     45.7
  **Prevalence of most common stroke risk factors**                                                           
  Hypertension, %                                                                                             
   Male                                                                    43.8             40.5     58.3     53.6
   Female                                                                  56.2             59.5     41.7     46.4
   *P*-value[a](#tfn11-ijwh-6-585){ref-type="table-fn"}                    0.0362           NS       NS       NS
  Diabetes mellitus, %                                                                                        
   Male                                                                    48.7             41.2     57.3     50.6
   Female                                                                  51.4             58.8     42.7     49.4
   *P*-value[a](#tfn11-ijwh-6-585){ref-type="table-fn"}                    0.0287           NS       NS       NS
  Cardiac disease, %[c](#tfn13-ijwh-6-585){ref-type="table-fn"}                                               
   Male                                                                    47.0             43.8     68.7     59.7
   Female                                                                  53.0             56.2     31.3     40.3
  Dyslipidemia, %                                                                                             
   Male                                                                    48.0             38.2     65.0     50.0
   Female                                                                  52.0             61.8     35.0     50.0
   *P*-value[a](#tfn11-ijwh-6-585){ref-type="table-fn"}                    0.0374           NS       NS       NS
  Smoking history, %                                                                                          
   Male                                                                    58.0             55.9     92.0     76.2
   Female                                                                  42.0             44.1     8.0      23.8
   *P*-value[a](#tfn11-ijwh-6-585){ref-type="table-fn"}                    \<0.0001         0.0009   0.0005   0.0271
  Previous stroke/TIA[d](#tfn14-ijwh-6-585){ref-type="table-fn"}                                              
   Male                                                                    47.5             39.0     61.2     50.7
   Female                                                                  52.5             61.0     38.2     49.3
  Any combination[e](#tfn15-ijwh-6-585){ref-type="table-fn"}                                                  
   Male                                                                    41.9             41.6     56.0     54.3
   Female                                                                  58.1             58.4     44.0     45.7
   *P*-value[a](#tfn11-ijwh-6-585){ref-type="table-fn"}                    0.0045           NS       NS       NS

**Notes:**

χ^2^ test for differences between racial/ethnic groups

if *P*-values for statistical test were entirely not statistically significantly different by sex within racial/ethnic groups they were omitted from the table

cardiac disease includes atrial fibrillation, prost heart valve, coronary artery disease/prior myocardial infarction, carotid stenosis, peripheral vascular diseases, and heart failure

TIA duration \<24 hours

any combination of these risk factors.

**Abbreviations:** NS, not significant at *P*\<0.05 level; prost, prosthetic; TIA, transient ischemic attack.

###### 

Percentages of clinical diagnosis related to acute stroke, by sex within racial/ethnic groups[a](#tfn17-ijwh-6-585){ref-type="table-fn"}

  Diagnosis                                                                                                          Race/ethnicity[b](#tfn18-ijwh-6-585){ref-type="table-fn"}                   
  ------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------- ------- ------- -------
  Ischemic stroke (n=1,541)[c](#tfn19-ijwh-6-585){ref-type="table-fn"},[d](#tfn20-ijwh-6-585){ref-type="table-fn"}                                                                               
   Male                                                                                                              44.0                                                        40.4    58.8    52.4
   Female                                                                                                            56.0                                                        59.6    41.2    47.6
  Large artery atherosclerosis (n=360)                                                                                                                                                           
   Male                                                                                                              42.3                                                        48.3    44.4    56.3
   Female                                                                                                            57.7                                                        51.7    55.6    43.7
  Small artery occlusions (n=354)                                                                                                                                                                
   Male                                                                                                              47.1                                                        31.8    52.5    44.0
   Female                                                                                                            52.9                                                        68.2    47.5    56.0
  Cardioembolism (n=261)                                                                                                                                                                         
   Male                                                                                                              43.5                                                        61.8    81.8    50.0
   Female                                                                                                            56.5                                                        38.2    18.2    50.0
  Stroke of other determined and undetermined causes (n=547)                                                                                                                                     
   Male                                                                                                              42.8                                                        36.3    68.8    55.2
   Female                                                                                                            57.2                                                        65.7    31.3    44.8
  TIA[e](#tfn21-ijwh-6-585){ref-type="table-fn"} (n=1,179)                                                                                                                                       
   Male                                                                                                              44.5                                                        35.8    61.5    51.1
   Female                                                                                                            55.5                                                        64.2    38.5    48.9
  Subarachnoid hemorrhage (n=129)                                                                                                                                                                
   Male                                                                                                              36.6                                                        44.0    50.0    57.1
   Female                                                                                                            63.4                                                        56.0    50.0    42.9
  Intracerebral hemorrhage (n=380)                                                                                                                                                               
   Male                                                                                                              52.2                                                        54.2    58.3    55.9
   Female                                                                                                            47.8                                                        45.8    41.7    44.1
  Stroke not otherwise specified (n=23)                                                                                                                                                          
   Male                                                                                                              42.9                                                        50.0    100.0   100.0
   Female                                                                                                            57.1                                                        50.0    0.0     0.0
  No stroke-related diagnosis (n=21)                                                                                                                                                             
   Male                                                                                                              75.0                                                        0.0     50.0    75.0
   Female                                                                                                            25.0                                                        100.0   50.0    25.0

**Notes:**

Less than 0.5% of data was missing

χ^2^ test for differences between sexes within a racial/ethnic group

ischemic stroke subtyping, based on classification scheme from the Trial of ORG 10172 in Acute Stroke Treatment (TOAST)

approximately 1.2% of the data of ischemic stroke patients lacked subtyping information

TIA duration \<24 hours.

**Abbreviation:** TIA, transient ischemic attack.

###### 

Relative risk, stroke risk factors as predictors of ischemic stroke subtypes,[a](#tfn23-ijwh-6-585){ref-type="table-fn"} by sex within racial/ethnic groups

  Variable                       Relative risk (95% CI)                                                                       
  ------------------------------ ------------------------ ------------------- ----------------------------------------------- -----------------------------------------------
  Age (per 10 years)                                                                                                          
   Male                          0.98 (0.87--1.11)        1.22 (1.05--1.41)   0.83 (0.58--1.17)                               1.13 (0.86--1.49)
   Female                        1.20 (1.06--1.37)        0.98 (0.76--1.26)   1.27 (1.02--1.58)                               1.20 (0.93--1.55)
  Smoking (Yes =1, No =0)                                                                                                     
   Male                          1.03 (0.73--1.46)        0.98 (0.51--1.88)   --[b](#tfn24-ijwh-6-585){ref-type="table-fn"}   --[c](#tfn25-ijwh-6-585){ref-type="table-fn"}
   Female                        1.82 (1.36--2.45)        1.01 (0.33--3.15)   --                                              --
  HDL (per 10 mg/dL)                                                                                                          
   Male                          0.91 (0.78--1.05)        0.75 (0.61--0.93)   0.62 (0.35--1.09)                               1.09 (0.92--1.30)
   Female                        0.88 (0.80--0.96)        1.06 (0.95--1.18)   0.93 (0.74--1.18)                               1.01 (0.73--1.40)
  Triglycerides (per 10 mg/dL)                                                                                                
   Male                          0.99 (0.97--1.01)        0.94 (0.88--1.00)   0.98 (0.93--1.04)                               1.01 (0.97--1.05)
   Female                        0.97 (0.95--1.00)        0.99 (0.94--1.05)   1.01 (0.99--1.02)                               0.99 (0.93--1.04)

**Notes:**

Ischemic stroke subtyping based on classification scheme from the Trial of ORG 10172 in Acute Stroke Treatment (TOAST)

due to the absence of women smokers in a dataset for South Asians, no comparison was done

regression equation did not converge when smoking was included in the variable, small sample size-smoking was not included in the analysis.

**Abbreviations:** CI, confidence interval; HDL, high-density lipoprotein.
